[VRTX] YoY Quarter Result on 31-Mar-2014 [#Q1]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
05-May-2014
Financial Year
2014
Quarter
31-Mar-2014 [#Q1]
Profit Trend
QoQ- -624.91%
YoY- 24.53%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Revenue 714,718 398,080 138,509 118,451 328,368 438,737 73,662 45.99%
PBT 253,533 -30,617 -198,405 -231,654 -442,940 87,908 -176,096 -
Tax 3,985 5,485 299 803 -130,313 32 8,099 -11.13%
NP 247,756 -41,631 -198,606 -232,457 -308,016 91,590 -176,096 -
Tax Rate -1.57% - - - - -0.04% - -
Total Cost 466,962 439,711 337,115 350,908 636,384 347,147 249,758 10.98%
Ratio Analysis
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
NP Margin 34.66 -10.46 -143.39 -196.25 -93.80 20.88 -239.06 -
Per Share
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
EPS 1.01 -0.17 -0.83 -1.00 -1.43 0.44 -0.87 -
EPS Diluted 0.99 -0.17 -0.83 -1.00 -1.43 0.43 -0.87 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.